Dany Morisset Email & Phone Number

Antwerp, Be

Des Moines, Iowa, Us

Leading a group of key business product portfolio “Global Strategic Portfolios” with a focus on accelerating theportfolio's growth across Kemin business units and geographies. My role is essentially to work with other Business Units Presidents, senior leadership and cross-functional teams to drive profitable business growth, deliver sales and gross margin targets according to global and regional strategic plans. Leading the product innovation process in partnership with R&D in new product development and life cycle management of my intestinal health portfolio.

Des Moines, Iowa, Us

I ensure business continuity, and oversee and set strategy for Kemin EMENA Quality, Intellectual Property and Regulatory Affairs. Reporting to CEO (President) Kemin Agrifoods EMENA

Nevele (Gent Region), Be

Plant biotechnology, molecular biology and biochemistryMy activities:- Management of the QC laboratory including operational budgets- Control of product compliance with the company Stewardship requirements- Study Monitor for new assay validations- Scientific expertise, supporting regulatory science and regulatory affairs- Expertise to support accreditation to ISO 17025 standards for QC laboratories, globally- Preparation of QA/QC guidelines.

Ajdovščina, Si

Plant biotechnology, molecular biology and biochemistryMy current activities:- Research and development of new vaccine production platforms in plant using plant viral genome. - Preparation of QA guidelines. - Purification and assembly/disassembly process of the protein units. - Introduction of fast detection methods.- Participation to the European COST Action FA0804. Molecular Farming: Plant as a. Production Platform for High Value Proteins

Ljubljana, Si

Biotechnology and Molecular BiologyActivities: - Development of new nucleic acid-based amplification/detection assays based on qPCR, digital PCR, LAMP and NASBA/NAIMA with focus on portability, easiness, multiplexing and high throughput screening (microarray). Set-up of assay validations.- Coordination of R&D projects in Food safety and Plant Health areas at domestic (NIB), National (ARRS) and international (ERANET SAFEFOODERA, UK FSA) levels.- Scientific and regulatory expert in several European Network of GMO Laboratories (ENGL) and standardization (Slovenian and CEN) working groups.- Maintenance and improvement of the Quality System (QA/QC) for GMO testing (ISO 17025).- Introduction of new assays, in-house validation, SOP preparation and staff training for the National reference laboratory for GMO detection, under flexible scope of ISO 17025 accreditation.- Responsible analyst for the detection of Genetically Modified Organisms (GMOs) in food, feed and seeds. - Auditor for internal audits at NIB and other external laboratories.

Québec, Qc, Ca

The key aim of my research was to study the function and the structure of putative proteins harbouring one or several whey acidic protein (WAP) domains. WAP proteins are suspected to be serine protease inhibitors since this motif characterises two well-known elastase inhibitors expressed in numerous epithelia: secretory leukoprotease inhibitor (SLPI) and pre-elafin. The focus of this work was on the HE4 protein and its potential physiological and physiopathological roles in lung inflammation, bacterial antagonism and cell proliferation. Keywords: Lung inflammation, emphysema, anti-elastolytic activity, bacterial antagonism, non small-cell lung carcinomas, RT-PCR, production of recombinant proteins, cell proliferation, angiogenesis, serine proteases.Techniques: Expression and purification of potential human proteins in Yeast. Characterisation (biological and structural). Enzymology, microbiology, Cell Biology, Molecular cloning and Biology, 3D modelling, affinity chromatography, Circular dichroism...

Poitiers, Nouvelle-Aquitaine, Fr

The key aim of my research was to study the function and the structure of a bacteriocin produced by the Lactic Acid Bacteria Leuconostoc mesenteroides Y105. Mesentericin Y105 is a sub-class IIa bacteriocin produced by Leuconostoc mesenteroides Y105.A bank of mesentericins Y105 peptide derivates was created using, randomly primed PCR mutagenesis to create single mutations in the DNA sequences that encode the mature peptide.A method for heterologous production based on a two component system with one vector harbouring structural gene, and one other encoding the immunity protein and transport system was optimized. Thus, an universal peptide secretion tool has been established. The impact of mutations was studied for the mesentericin Y105 derivatives, by accessing their activity, secondary structure, predicted tertiary structure and interaction with anisotropic environment. Finally, a nuclear magnetic resonance analysis was used to determinate the native bacteriocin structure.A general model for the mechanism of action of mesentericin Y105 and its related bacteriocins is proposedKeywords: Food health, lactic acid bacteria, bacterial antagonism, bacteriocins, Listeria, circular dichroism, NMR, tryptophan blue shift, heterologous production, randomly mutagenesis.Techniques: Expression and structure/function studies of recombinant bacteriocins produced in exogenous host. Circular dichroism, molecular cloning, affinity chromatography, exchange chromatography, 3D modellingOther activities:Lectures in microbiology, biochemistry (metabolism), biophysics and molecular biology.

Poitiers, Nouvelle-Aquitaine, Fr

The key aim of my research was to study the function and the structure of a bacteriocin produced by the Lactic Acid Bacteria Leuconostoc mesenteroides Y105. Mesentericin Y105 is a sub-class IIa bacteriocin produced by Leuconostoc mesenteroides Y105.A bank of mesentericins Y105 peptide derivates was created using, randomly primed PCR mutagenesis to create single mutations in the DNA sequences that encode the mature peptide.A method for heterologous production based on a two component system with one vector harbouring structural gene, and one other encoding the immunity protein and transport system was optimized. Thus, an universal peptide secretion tool has been established.The impact of mutations was studied for the mesentericin Y105 derivatives, by accessing their activity, secondary structure, predicted tertiary structure and interaction with anisotropic environment. Finally, a nuclear magnetic resonance analysis was used to determinate the native bacteriocin structure.A general model for the mechanism of action of mesentericin Y105 and its related bacteriocins is proposedKeywords: Food health, lactic acid bacteria, bacterial antagonism, bacteriocins, Listeria, circular dichroism, NMR, tryptophan blue shift, heterologous production, randomly mutagenesis.Techniques: Expression and structure/function studies of recombinant bacteriocins produced in exogenous host. Circular dichroism, molecular cloning, affinity chromatography, exchange chromatography, 3D modellingOther activities:Lectures in microbiology, biochemistry (metabolism), biophysics and molecular biology.

Master Of Business Administration - Mba, Business/Managerial Economics

Postdoctoral Degree, Biotechnology And Biochemistry, Cell Biology

Phd, Biochemistry, Microbiology, Molecular Biology

Education record